Developing brain as a target of toxicity.

The human brain forms over an unusually long period compared to other organs. While most of the basic structure is laid down before birth, neuron proliferation and migration continue in the postnatal period. The blood-brain barrier is not fully developed until the middle of the first year of life. The number of synaptic connections between neurons reaches a peak around age two and is then trimmed back by about half. Similarly, there is great postnatal activity in the development of receptors and transmitter systems as well as in the production of myelin. Many of the toxic agents known to damage the developing brain interfere with one or more of these developmental processes. Those with antimitotic action, such as X-ray and methyl mercury, have distinctly different effects on structure depending on which neurons are forming at the time of exposure. Vulnerability to agents that interfere with cell production decreases rapidly over the early postnatal period. Other toxic substances, such as psychoactive drugs and agents that alter hormone levels, are especially hazardous during synaptogenesis and the development of transmitter systems, and thus continue to be damaging for years after birth. Still other toxic substances such as lead, seem to have their greatest effects during even later stages of brain development, perhaps by interfering with the trimming back of connections. Guidelines designed to protect human populations from developmental neurotoxicity need to take into account the changing sensitivity of the brain as it passes through different developmental stages, as well as the fundamental differences in the effects of toxicants on the mature and the developing brain.

[1]  M. Adinolfi,et al.  THE DEVELOPMENT OF THE HUMAN BLOOD‐CSF‐BRAIN BARRIER , 1985, Developmental medicine and child neurology.

[2]  L. Cooper,et al.  Clinical manifestations of postnatal and congenital rubella. , 1967, Archives of ophthalmology.

[3]  A. Levin,et al.  Fetal toxicity of cadmium in the rat: Maternal vs fetal injections , 1980 .

[4]  O. H. Lowry,et al.  Uptake of Exogenous Glutamate and Aspartate by Circumventricular Organs but Not Other Regions of Brain , 1981, Journal of neurochemistry.

[5]  L. Lapham,et al.  ABNORMAL NEURONAL MIGRATION, DERANGED CEREBRAL CORTICAL ORGANIZATION, AND DIFFUSE WHITE MATTER ASTROCYTOSIS OF HUMAN FETAL BRAIN: A MAJOR EFFECT OF METHYLMERCURY POISONING IN UTERO , 1978, Journal of neuropathology and experimental neurology.

[6]  R. Kavlock,et al.  Prenatal exposure to the herbicide 2,4-dichlorophenyl-p-nitrophenyl ether destroys the rodent Harderian gland. , 1982, Science.

[7]  H. Rosengarten,et al.  Enduring changes in dopamine receptor cells of pups from drug administration to pregnant and nursing rats. , 1979, Science.

[8]  C. D'amato,et al.  The development of the mammalian nervous system I. Malformations of the brain, especially the cerebral cortex, induced in rats by radiation II. Some mechanisms of the malformations of the cortex , 1959, The Journal of comparative neurology.

[9]  P. Rodier Behavioral Effects of Antimitotic Agents Administered during Neurogenesis , 1986 .

[10]  R. Wiggins Myelin development and nutritional insufficiency , 1982, Brain Research Reviews.

[11]  R. Jensh,et al.  Ionizing radiation and the developing brain. , 1990, Neurotoxicology and teratology.

[12]  B. Weiss,et al.  Methylmercury developmental neurotoxicity: a comparison of effects in humans and animals. , 1990, Neurotoxicology and teratology.

[13]  T. Kemper,et al.  Histoanatomic observations of the brain in early infantile autism , 1985, Neurology.

[14]  P. Huttenlocher,et al.  The development of synapses in striate cortex of man. , 1987, Human neurobiology.

[15]  I. Black Stages of Neurotransmitter Development in Autonomic Neurons , 1982, Science.

[16]  M. Miller,et al.  Thalidomide embryopathy: a model for the study of congenital incomitant horizontal strabismus. , 1991, Transactions of the American Ophthalmological Society.

[17]  M. Aschner,et al.  Mitotic arrest in the developing CNS after prenatal exposure to methylmercury. , 1984, Neurobehavioral toxicology and teratology.

[18]  Michael V. Johnston,et al.  Physiological and pathophysiological roles of excitatory amino acids during central nervous system development , 1990, Brain Research Reviews.

[19]  D Bellinger,et al.  The long-term effects of exposure to low doses of lead in childhood. An 11-year follow-up report. , 1990, The New England journal of medicine.

[20]  A. Streissguth,et al.  Pattern of Malformation in Offspring of Chronic Alcoholic Mothers , 1995, Alcohol health and research world.

[21]  P. Rodier Chronology of Neuron Development: Animal Studies and their Clinical Implications , 1980, Developmental medicine and child neurology.

[22]  P. Rodier,et al.  Effects of methylmercury on developing mouse cerebellar cortex , 1982, Experimental Neurology.

[23]  J. Lauder,et al.  Neurotransmitters as morphogens. , 1988, Progress in brain research.

[24]  J. Eayrs The cerebral cortex of normal and hypothyroid rats. , 1955, Acta anatomica.

[25]  T. Clarkson,et al.  Intra-uterine methylmercury poisoning in Iraq. , 1974, Pediatrics.

[26]  M. Gnant,et al.  Prevention of neural tube defects: Results of the Medical Research Council Vitamin Study , 1991, The Lancet.

[27]  B. Cragg,et al.  The development of synapses in the visual system of the cat , 1975, The Journal of comparative neurology.

[28]  FranzW. Rosa,et al.  TERATOGENICITY OF ISOTRETINOIN , 1983, The Lancet.

[29]  J Dobbing,et al.  Synapse‐to‐neuron ratios of the frontal and cerebellar cortex of 30‐day‐old and adult rats undernourished during early postnatal life , 1980, The Journal of comparative neurology.

[30]  E. Silbergeld,et al.  The long-term effects of exposure to low doses of lead in childhood. , 2010, The New England journal of medicine.

[31]  Prevention of neural tube defects: Results of the Medical Research Council vitamin study , 1991 .